Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (SHE:002932)
China flag China · Delayed Price · Currency is CNY
16.33
-0.23 (-1.39%)
May 21, 2026, 3:04 PM CST

SHE:002932 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
776.81510.9493.911,0162,5561,190
Short-Term Investments
-2,980850.86102.4370-
Trading Asset Securities
2,075394.3564.12122.591,953700
Cash & Short-Term Investments
2,8523,8851,4091,2414,5781,890
Cash Growth
-11.56%175.74%13.56%-72.90%142.22%117.48%
Accounts Receivable
448.83469.98766.951,2542,736740.42
Other Receivables
56.5113.5380.5270.2817.5211.97
Receivables
505.33583.5847.471,3242,754752.39
Inventory
95.7165.182.3128.77258.44284.59
Other Current Assets
1,246149.4759.0256.491.0972.98
Total Current Assets
4,6994,6832,3982,7507,6823,000
Property, Plant & Equipment
649.96632.16721.68543.6525.97243.47
Long-Term Investments
247.07247.07257.61156.3683.4960.62
Other Intangible Assets
31.3626.5417.317.716.8616.59
Long-Term Deferred Tax Assets
212.23212.44216.9210.18173.9516.63
Long-Term Deferred Charges
6.432.13.1114.8717.211.45
Other Long-Term Assets
152.38177.052,9793,694695.3378.24
Total Assets
6,0195,9806,5937,3879,1953,417
Accounts Payable
98.2581.32278.11681.581,294174.31
Accrued Expenses
38.2248.6787.97154.94364.6883.18
Short-Term Debt
122323.61164.6730
Current Portion of Leases
-2.544.37.2918.173.62
Current Income Taxes Payable
-0.346.446.27144.02131.8
Current Unearned Revenue
31.921.4937.9653.17309.5871.18
Other Current Liabilities
75.784.6478.0792.569.9651.9
Total Current Liabilities
256.07240.99495.861,0192,365545.98
Long-Term Leases
10.313.195.8218.2520.7510.74
Long-Term Unearned Revenue
26.526.520.8714.265.965.96
Long-Term Deferred Tax Liabilities
53.8352.7650.4239.5931.074.33
Other Long-Term Liabilities
1.141.141.443.03--
Total Liabilities
347.84324.56574.41,0942,423567.02
Common Stock
232.52232.52232.52232.52156.19104.88
Additional Paid-In Capital
818.1818.1818.1820.18887.89904.5
Retained Earnings
4,7344,7345,0144,9735,4721,812
Treasury Stock
-248.61-247.96-237.95--16.02-32.77
Comprehensive Income & Other
-8.34-8.34----
Total Common Equity
5,5275,5285,8266,0266,5002,789
Minority Interest
143.75127.33192.29266.21271.9261.25
Shareholders' Equity
5,6715,6566,0196,2926,7722,850
Total Liabilities & Equity
6,0195,9806,5937,3879,1953,417
Total Debt
22.37.7213.1149.16203.5944.36
Net Cash (Debt)
2,8293,8771,3961,1924,3751,846
Net Cash Growth
-11.90%177.78%17.14%-72.76%137.02%153.67%
Net Cash Per Share
-16.496.185.2519.038.72
Filing Date Shares Outstanding
-219.49220.05232.52232.73232.84
Total Common Shares Outstanding
-219.49220.05232.52232.73232.84
Working Capital
4,4434,4421,9021,7315,3172,454
Book Value Per Share
-25.1926.4825.9227.9311.98
Tangible Book Value
5,4755,5025,8096,0086,4832,772
Tangible Book Value Per Share
-25.0726.4025.8427.8611.91
Buildings
-496.88440.3116.98116.6678
Machinery
-394.69380.8402.91374.05158.18
Construction In Progress
--120.79185.19121.5273.58
Source: S&P Global Market Intelligence. Standard template. Financial Sources.